Abstract

The advancement of ultrasound-mediated therapy has stimulated the development of drug-loaded microbubble agents that can be targeted to a region of interest through an applied magnetic field prior to ultrasound activation. However, the need to incorporate therapeutic molecules while optimizing the responsiveness to both magnetic and acoustic fields and maintaining adequate stability poses a considerable challenge for microbubble synthesis. The aim of this study was to evaluate three different methods for incorporating iron oxide nanoparticles (IONPs) into phospholipid-coated microbubbles using (1) hydrophobic IONPs within an oil layer below the microbubble shell, (2) phospholipid-stabilized IONPs within the shell, or (3) hydrophilic IONPs noncovalently bound to the surface of the microbubble. All microbubbles exhibited similar acoustic response at both 1 and 7 MHz. The half-life of the microbubbles was more than doubled by the addition of IONPs by using both surface and phospholipid-mediated loading methods, provided the lipid used to coat the IONPs was the same as that constituting the microbubble shell. The highest loading of IONPs per microbubble was also achieved with the surface loading method, and these microbubbles were the most responsive to an applied magnetic field, showing a 3-fold increase in the number of retained microbubbles compared to other groups. For the purpose of drug delivery, surface loading of IONPs could restrict the attachment of hydrophilic drugs to the microbubble shell, but hydrophobic drugs could still be incorporated. In contrast, although the incorporation of phospholipid IONPs produced more weakly magnetic microbubbles, it would not interfere with hydrophilic drug loading on the surface of the microbubble.

Highlights

  • Gas microbubbles (MBs) stabilized by a surfactant or a polymer shell were initially developed as contrast agents to enhance ultrasound imaging of the vasculature.[1]

  • OilMB exhibited a significantly lower yield and larger mean diameter compared to all other groups, with approximately 10 times fewer bubbles produced of double the size. This effect could be due to the excess surfactanta present in the isoparaffin iron oxide nanoparticles (IONPs) suspension disrupting the phospholipid coating or due to the oil phase itself reducing the coating integrity

  • The addition of LαPC IONPs (Figure 6C) reduced the surfactant “squeeze-out” plateau, indicating retention of PEG40S in the monolayer beyond 35 mN/m, and led to a lower monolayer collapse pressure. These results suggest that the addition of LαPC IONPs to DBPC/PEG40S MBs may reduce the loss of PEG40S during compression

Read more

Summary

Introduction

Gas microbubbles (MBs) stabilized by a surfactant or a polymer shell were initially developed as contrast agents to enhance ultrasound imaging of the vasculature.[1]. A further complementary application of MBs is as therapeutic carriers of highly potent drugs. MBs must have adequate stability both in storage and in circulation. They must be sufficiently responsive to ultrasound to promote therapy and ideal to be imaged during treatment. They must be able to carry sufficient quantities of drug to be effective; and it is desirable to be able to target them to specific sites, for example, tumor endothelium

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call